ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
2.630
+0.040 (1.54%)
Dec 20, 2024, 4:00 PM EST - Market closed
ProQR Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$7.60
Upside
+188.97%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $8 | Buy | Reiterates | $8 | +204.18% | Dec 12, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $4 | Strong Buy | Maintains | $4 | +52.09% | Dec 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +280.23% | Dec 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $10 | Strong Buy | Maintains | $5 → $10 | +280.23% | Nov 8, 2024 |
| Raymond James | Raymond James | Buy → Strong Buy Upgrades $6 → $14 | Buy → Strong Buy | Upgrades | $6 → $14 | +432.32% | Oct 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +90.11% | May 10, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $2.5 | Strong Buy | Maintains | $2.5 | -4.94% | May 10, 2024 |
| Citigroup | Citigroup | Hold Maintains $1.8 → $2 | Hold | Maintains | $1.8 → $2 | -23.95% | Apr 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +90.11% | Mar 14, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $2 → $2.5 | Strong Buy | Maintains | $2 → $2.5 | -4.94% | Mar 14, 2024 |
| Raymond James | Raymond James | Buy Maintains $5 → $4 | Buy | Maintains | $5 → $4 | +52.09% | Nov 8, 2023 |
| Chardan Capital | Chardan Capital | Hold → Strong Buy Upgrades $2 | Hold → Strong Buy | Upgrades | $2 | -23.95% | Nov 8, 2023 |
| Citigroup | Citigroup | Hold Maintains $2.1 → $1.8 | Hold | Maintains | $2.1 → $1.8 | -31.56% | Sep 18, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +90.11% | Aug 7, 2023 |
| Chardan Capital | Chardan Capital | Hold Reiterates $2 | Hold | Reiterates | $2 | -23.95% | Aug 4, 2023 |
| Citigroup | Citigroup | Hold Maintains $2.25 → $2.1 | Hold | Maintains | $2.25 → $2.1 | -20.15% | May 26, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.